Background: Along with the rapid development of genetic engineering technology and antibody engineering technology, humanized monoclonal antibody has been rapidly developed and gradually replaces the rat sourced monoclonal antibody. In this paper, we establish two new logarithmically completely monotonic functions involving the real-valued special functions according to two preferred interaction geometries, necessary and sufficient conditions are presented for one of them to be logarithmically completely monotonic. As a consequence, a sharp inequality involving the real-valued special functions is deduced to solve the problems of genetically engineered antibody.
Introduction
Antibodies have been proven to be indispensable tools for biomedical applications. Different engineered antibodies have been developed for various purposes according to the amino acid sequence and/or spatial structure of protein (Figure 1 ). At present, it is still difficult to predict the optimal structure of antibodies. Topology knowledge can be important in antibody application as well as transformation. Theoretically, we can obtain desired antibodies by using protein/gene engineering technology. For instance, we can transform the complementarity determining region (CDR) to promote the affinity of the antibody to antigen. Similarly, we could also transform any domain of antibody to make it bind with any desired target. Under this vision, topology is a powerful tool to predict the structure of protein and it will serve to antibody engineering. Our present work tries to explain, and predict, if possible, the change of structure, size and function of antibodies as well as their fragments from a topological perspective. for all x I ∈ and for all 0 n ≥ . If inequality (1.5) is strict for all x I ∈ and all 0 n ≥ , then f is said to be strictly completely monotonic [2] [3] [4] [5] . We recall also that a positive function f is said to be logarithmically completely monotonic on an interval I if f has derivatives of all orders on I and
for all x I ∈ and for all 1 n ≥ . If inequality (1.7) is strict for all x I ∈ and all 1 n ≥ , then f is said to be strictly logarithmically completely monotonic [7] [8] [9] .
The antibody structure will be changed when it binds certain targets (Figure 2a) , i.e.: antigen, receptor. How to describe the changes in the view of topology? The following cases will explain it in detail. 
It was proved explicitly in and other articles that a logarithmically completely monotonic function must be completely monotonic [8] .
In [10] From (1.9) and the monotonicity of g(x), then the double inequalities ( )
holds for all x>0.
In [11, Theorem 1] , by using the well-known Binet's formula, H. Alzer generalized the monotonicity and convexity of g (x) , that is, the function
is strictly completely monotonic on ( ) In [12] , D. Kershaw and A. Laforgia proved that the function ( ) After the papain digestion, the remained antibody functional part (usually the Fab domain), will be smaller and the structure is also changed (Fig. 1b) . These changes can be revealed vividly using topology. Recently 
Antibodies occur spontaneously gathering and forming dimer, polymer, which will influence their functions (Figure 2b ). In antibody engineering practice, it urgently needs some measures to overcome this difficulty. From topology perspective, we could understand this issue as follow. Our second result is presented in the following theorem.
Theorem 2: For any given
where γ denotes the Euler's constant, then the function (1.14) is strictly logarithmically completely monotonic with respect to x on ( )
The following corollary can be derived from Theorems 2 immediately.
Corollary 1:
For any given
Lemma
In order to prove our main results, we need the following lemmas.
It is well known that Bernoulli polynomials numbers E n are defined by E n = 2 n E n (1/2).
In [16] , the following summation formula is given:
for any nonnegative integer k, which implies
In particular, it is known that for all n ∈  we have ( ) The Bernoulli and Euler numbers and polynomials are generalized ( [18] [19] [20] [21] ).
Lemma 1:
For real number x > 0 and natural number m [22, 23] , then ( ) ( ) 
Lemma 3: (see [1, 17] For given integer
and, by the identities (2.13) and (2.14), (2.23) can be written as 
The following two cases will complete the proof of Lemma 5. The lemma is proved.
Proof of Theorems
Proof of Theorem 1: For 0 x ≠ and natural number n, taking the logarithmically differential into consideration yields
where ( ) ( ) Furthermore, differentiating
Making use of (2.11) and (2.13) shows that for all n ∈  and any fixed y >0, the double inequality .
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From (3.3) and (3.8)-(3.9), it is easy to see that ( ) 
for n ∈  . It is obvious that (3.18) is equivalent to that (3.14) and (3.15) hold for any given y > 0 and
. Therefore, it is easy to prove similarly that (3.16) is also valid on ( )
,0 x y ∈ − for any given y > 0 and all n ∈  .
The amino acid of antibody/protein possesses different preferences. Thus we can conduct site-directed mutation to promote the affinity and/or hydrophilic with the prediction of topology. For example, bovine antibodies have an unusual structure comprising a β-strand 'stalk' domain and a disulphide-bonded 'knob' domain in CDR3 (Figure 3) . Attempts have been made to utilize such amino acid preference for antibody drug development. for any given y > 0. In fact, it is not difficult to show that the necessary condition for the function (1.13) to be strictly logarithmically completely monotonic is 1 α ≥ .
The proof of Theorem 1 is completed.
Proof of Theorem 2:
Taking the logarithm of ( ) for all x > 0.
Theorem 2 follows from (3.32) and (3.33).
Thus the proof of Theorem 2 is completed.
Conclusion
In conclusion, we establish two new logarithmically completely monotonic functions involving the real-valued special functions according to two preferred interaction geometries, and a sharp inequality involving the real-valued special functions is deduced to solve the problems of genetically engineering antibodies. It is necessary to address, many other aspects (such as thermal condition, alkalinity or acidity, adhesion of antibodies) are also playing key roles in antibodies functioning, which could be also understood from bio-mathematical perspective, and such knowledge will be in return useful for biomedical application of antibodies as well as proteins [25] [26] [27] [28] [29] [30] .
Acknowledgements
We would like to express my gratitude to all those who helped us during the writing of this article.
( ) holds for all x > 0.
And then by using inequality (1.9) and (1.10), we get
